Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▲ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Boston Scientific | 45 | 0 | 12 | 0 | €68.50 | €73.05 | 6.638% |
| Rewalk Robotics Ltd. | 1 | 12 | 0 | 0 | €5.00 | - | - |
| Alkermes plc | 12 | 2 | 2 | 0 | €22.40 | €34.08 | 52.146% |
| Ardelyx Inc. | 2 | 0 | 0 | 0 | €6.00 | €15.50 | 158.506% |
| UnitedHealth Group Inc. | 33 | 1 | 7 | 0 | €462.95 | €543.72 | 17.447% |
| Chromadex Corp | 10 | 2 | 1 | 0 | €3.26 | €5.76 | 76.577% |
| Maternus-Kliniken AG | 1 | 0 | 0 | 0 | €1.81 | €1.65 | -8.840% |
| Dexcom Inc. | 18 | 0 | 3 | 0 | €116.18 | €136.82 | 17.767% |
| Avid Bioservices Inc | 2 | 0 | 1 | 0 | €6.50 | €8.75 | 34.615% |
| Valneva SE | 2 | 0 | 0 | 0 | €3.51 | €7.00 | 99.544% |
| Krystal Biotech | 16 | 0 | 3 | 0 | €145.15 | €173.22 | 19.338% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €363.30 | €421.61 | 16.049% |
| Dentsply Sirona Inc. | 10 | 0 | 0 | 0 | €28.20 | €38.55 | 36.709% |
| Stoke Therapeutics Inc | 15 | 1 | 6 | 0 | €10.60 | €21.39 | 101.821% |
| Brainstorm Cell | 1 | 0 | 0 | 0 | €0.47 | - | - |
| Personalis Inc | 5 | 0 | 1 | 0 | €1.16 | €3.23 | 178.585% |
| XOMA Corp. | 4 | 0 | 1 | 0 | €22.80 | €68.78 | 201.664% |
| aTyr Pharma Inc | 3 | 0 | 2 | 0 | €1.44 | €10.00 | 594.444% |
| Paul Hartmann AG | 3 | 0 | 0 | 0 | €209.00 | - | - |
| Ensign Group Inc. | 8 | 0 | 1 | 0 | €110.00 | €116.50 | 5.906% |
| Merit Medical Systems | 13 | 0 | 2 | 0 | €68.50 | €86.72 | 26.594% |
| Aveo Pharmaceuticals Inc. | 1 | 0 | 0 | 0 | €13.85 | €100.00 | 622.022% |
| United Therapeutics | 15 | 0 | 0 | 0 | €220.00 | €289.92 | 31.782% |
| Innoviva Inc. | 3 | 0 | 2 | 0 | €14.20 | €30.00 | 111.268% |
| Acorda Therapeutics Cdt | 14 | 0 | 1 | 0 | €0.47 | - | - |